Hospital for Special Surgery Shoulder Arthroplasty Cohort

Shoulder Arthroplasty Clinical Trial

Official title:

Prospective Evaluation of the Clinical and Economic Outcomes of Total Joint Replacement: HSS Shoulder Arthroplasty Cohort

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT00527839
• Other study ID #: 2013-014
• Status: Recruiting
• Start date: April 2007
• Est. completion date: April 2027

Study information

• Verified date: October 2023
• Source: Hospital for Special Surgery, New York
• Contact: Robert Marx, MD
• Phone: 212-606-1645
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Total joint replacements are some of the most successful medical devices developed over the last fifty years. They enable millions of people to remain ambulatory and pain free, with minimal risk. In 2002, over 200,000 total hip replacements, 350,000 total knee replacements, and 25,000 total or partial shoulder replacements were performed in the United States (HCUP data). Future use will likely be even higher: it is estimated that by the year 2020, the population 65 and over in developed countries will increase by 71%. Existing studies do not provide adequate prospective data to evaluate long-term outcomes.

HSS is a world leader in total joint replacement including total shoulder arthroplasty. However, there is no systematic follow-up or evaluation of patients who have their shoulders replaced here.

The purpose of this study is to establish a prospective cohort of HSS total shoulder arthroplasty to evaluate predictors of outcome, causes of failure and to allow ongoing evaluation of the results of our patients over time.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 250
• Est. completion date: April 2027
• Est. primary completion date: April 2027
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• 18 years or older and undergoing total shoulder arthroplasty at HSS

Exclusion Criteria:

• No other exclusion criteria. Pregnant women are eligible for the registry as this is a non-interventional study which only involves filling out questionnaires.

Related Conditions & MeSH terms

• Shoulder Arthroplasty

Locations

Country	Name	City	State
United States	Hospital for Special Surgery	New York	New York
United States	Hospital for Special Surgery	New York	New York

Sponsors (1)

Lead Sponsor	Collaborator
Hospital for Special Surgery, New York

Country where clinical trial is conducted

United States, 

External Links

•   CERTS tools and resources